Skip to content

On July 13, the Food and Drug Administration approved for the first time an over-the-counter birth control pill, expected to hit shelves in early 2024. The approval of the oral contraceptive Opill could drastically expand access to birth control, which for decades has been available only through a prescription. It’s a rare victory for reproductive rights — and the culmination of a 25-year effort to land birth control on drugstore shelves.   A central player in that push was Donald Downing,…

Using powerful tools and techniques developed in the field of structural biology, researchers at the University of Washington and Scripps Research have discovered new details about the human immunodeficiency virus, HIV. The findings bring into focus the basic architecture of the virus just above and below its surface and may help in the design and development of a vaccine that can protect against AIDS. These detailed findings include 3D views of the structure and position of the virus’ envelope “spike”…

The UW School of Pharmacy’s Drug Interaction Database — the core research tool from the school’s nonprofit Drug Interaction Solutions team — is celebrating both a national award for innovation and two decades of independent funding through licensing agreements with companies, research institutes and regulatory agencies around the globe.

Federal agencies that regulate drug pricing and healthcare insurance are concerned that an industry practice of using rebates to lower drug costs for insurers has led to increases in list prices and out-of-pockets costs for patients. To investigate whether patients with or without insurance were paying more because of rebates to insurers, researchers led by the University of Washington examined cost and price data on more than 400 branded drugs. The study found that rebates were associated with increases in…

The National Academy of Medicine on Monday announced the election of 100 new members, including three from the : Patrick Heagerty, Dr. Joel Kaufman and Sean Sullivan. In addition, David Eaton, dean and vice provost emeritus of the UW’s Graduate School, was recognized for outstanding service.

As universities and colleges struggle to find the right combination of in-person and online classes combined with protective measures to help prevent the spread of the novel coronavirus, a new study by researchers from four institutions has reached a troubling conclusion. Reopening university and college campuses with primarily in-person instruction is associated with a significant increase in cases of COVID-19 in the counties where the schools are located. “Consequently, we are able to predict between 1,000 and 5,000 additional cases…

The future of our health and the health of the communities we live in relies, in many ways, on students in the health sciences. The education and experiences that future doctors, dentists, pharmacists, nurses, social workers and public health experts receive will to a large degree shape how those professionals work and work together when solving problems affecting our health. And while the University of Washington’s highly ranked health sciences schools have long focused on interdisciplinary education and training students…

New research by the University of Minnesota and the University of Washington finds that every six additional ICU beds or seven additional non-ICU beds filled by COVID-19 patients leads to one additional COVID-19 death over the following week. “A spike in hospitalization naturally leads to more deaths, but these deaths may not only come from those who are hospitalized, but also from those who should have been hospitalized but were not,” said co-author Anirban Basu, a UW professor of health…

COVID-19 is a lot more deadly than the flu, according to a new study by the University of Washington published May 7 in the journal Health Affairs. The study’s results also project a grim future if the U.S. doesn’t put up a strong fight against the spread of the virus.

With $4 million in matching funds from the National Institutes of Health, the University of Washington has created a new integrated center to match biomedical discoveries with the resources needed to bring innovative products to the public and improve health. “The University of Washington and regional partner institutions produce some of the most exciting biomedical discoveries and technologies in the world, but we always find it challenging to support their product development as they move into the early commercialization phases,”…

The University of Washington’s School of Pharmacy announced on Thursday, Sept. 12, a collaboration with global biopharmaceutical company UCB to improve access to care for people living with epilepsy.This interdisciplinary project will explore ways in which community pharmacists can better support people living with this neurological disorder. The roughly 3.4 million people nationally and 75,000 people in Washington state who live with epilepsy often get fragmented and uncoordinated healthcare and community services. “For the growing population of people living with…